|List |< first << previous [record 6 of 17] next >> last >||
|Coordinate||70,571,429 bp (GRCm38)|
|Base Change||T ⇒ G (forward strand)|
|Synonym(s)||ALUNC, AU, N, ba, bldy, hr, rh, rh-bmh, rhino|
|Chromosomal Location||70,552,212-70,573,548 bp (+)|
FUNCTION: This gene encodes a protein that is involved in hair growth. This protein functions as a transcriptional corepressor of multiple nuclear receptors, including thyroid hormone receptor, the retinoic acid receptor-related orphan receptors and the vitamin D receptors, and it interacts with histone deacetylases. The translation of this protein is modulated by a regulatory ORF that exists upstream of the primary ORF. Mutations in this upstream ORF, U2HR, cause Marie Unna hereditary hypotrichosis (MUHH), an autosomal dominant form of genetic hair loss in human. [provided by RefSeq, Oct 2014]
PHENOTYPE: Mutant homozygotes exhibit hair loss, usually wrinkled skin with epidermal cysts. Females do not nurse their pups well. [provided by MGI curators]
|Amino Acid Change||Tyrosine changed to Aspartic acid|
|Institutional Source||Beutler Lab|
Y1082D in Ensembl: ENSMUSP00000022691 (fasta)
Y1111D in Ensembl: ENSMUSP00000124042 (fasta)
|Gene Model||not available|
|Predicted Effect||probably damaging
PolyPhen 2 Score 0.995 (Sensitivity: 0.67; Specificity: 0.97)
|Alleles Listed at MGI|
|Mode of Inheritance||Autosomal Recessive|
|Local Stock||Sperm, gDNA|
|Last Updated||2018-03-02 4:44 PM by Diantha La Vine|
The prune phenotype was discovered in an N-ethyl-N-nitrosourea (ENU)-induced G3 mutant mouse. Mutant mice develop a normal first coat, but beginning at two weeks of age hair loss begins from just above the eyes and progresses towards the posterior. By three weeks of age, animals have an almost universal absence of hair, with occasional hairs retained on the feet and snout. The skin is extremely loose and wrinkled, and the toenails are abnormally long (Figure 1). The animal has normal thymocyte (T) cell counts in the peripheral blood. The strain is being expanded for further analysis.
|Nature of Mutation|
The prune mutation is a T to G transversion at residue 3733 in the cDNA transcript ENSMUST00000163060, within exon 16 of 18 total exons. The mutated residue corresponds to position 3938 of the Hr transcript ENSMUST00000022691, in exon 18 of 20 total exons.
1106 -A--P--G--S--C--Y--L--D--A--G--L- (ENSMUSP00000124042)
1077 -A--P--G--S--C--Y--L--D--A--G--L- (ENSMUSP00000022691 & NP_068677)
The N-terminal region of the HR protein has no clearly defined secondary structure, but the rest of the HR protein (from amino acid 378) is predicted to form three α-helical regions interrupted by long loop regions including the region containing the zinc finger. The actual structure of the HR protein remains to be determined. A novel bipartite nuclear localization signal (NLS) was identified at amino acids 409-427 consisting of the sequence KRA(X13)PKR (6). Subsequently, a novel nuclear matrix targeting signal (NMTS) was also found in the HR protein at amino acids 111-156 that is necessary for its nuclear sub-localization (7).
Along with the potential DNA-binding domain, the HR protein contains several domains that suggest it is a nuclear receptor corepressor, including multiple nuclear receptor interacting domains and three repression domains capable of mediating nuclear receptor repressive activity in vitro (8). In the mouse protein, these repressive domains (RD) are located at amino acids 210-423 (RD1), 725-839 (RD2), and 839-956 (RD3). The RD2 domain contains regions that interact with the thyroid hormone receptor (TR), the retinoic acid receptor related orphan receptor α (RORα) and the vitamin D receptor (VDR) (8-10). Domains that have been shown to interact with TR are located at amino acids 792-805 (TR-ID1 for TR interacting domain 1) and amino acids 1001-1013 (TR-ID2) (8). RORα-interacting domains (ROR-ID) are located at amino acids 561-565 and 753-757 (9). The nuclear receptor interacting domains of HR consist of hydrophobic motifs, and are similar to nuclear receptor interacting motifs present in other nuclear receptor interacting proteins (6;8;9). Specifically, HR contains two LXXLL motifs known as nuclear receptor (NR) boxes that are present in nuclear receptor coactivators, and are known to interact with the α-helical AF-2 motif present in the ligand binding domain (LBD) of nuclear receptors (6;11). These motifs correspond to the RORα-interacting domains (9). The TR interacting motifs are similar to nuclear receptor interacting domains found in other nuclear receptor corepressors, and are thought to form amphipathic α helices (8;12;13).
The HR protein also contains a JmjC domain at amino acids 968-1179, which encompasses the TR-ID2 motif and partially overlaps with RD3 (7). Two proteins carrying this domain, JHDM1 (JmjC domain-containing histone demethylase 1) and JHDM2A, were found to have histone demethylase activity and be involved in transcriptional regulation (14). An alternatively spliced form of the Hr gene has been reported in humans that splices out exon 17 and removes part of the JmjC domain at amino acids 1072-1126 (4).
The prune mutation results in the substitution of a tyrosine with an aspartic acid in the JmjC domain. This amino acid is highly conserved across species.
Northern analysis in the mouse found only significant mRNA in the brain and skin, and in situ hybridization found expression in the skin to be in hair follicles (1). During embryonic development in the mouse, in situ hybridization found expression beginning at embryonic day (E)12.5 with strong mRNA levels in cartilage, and low levels in the epidermis, vibrissae, oral epithelium, tooth buds, submandibular gland, nasal epithelium, brain and inner ear. Other types of epithelium did not show any expression. At E16.5, strong expression continued in the cartilage, with low levels of hairless mRNA at later stages corresponding with the decrease in cartilage tissue. From E16.5 to later embryonic stages, moderate to strong expression levels of hr were found in epidermis, hair follicles, vibrissae, tooth buds, submandibular gland, and most epithelial layers. Hr was expressed throughout the brain at all stages with strongest expression found in the cortex, and some expression in the retina and optic nerve. In the tooth buds, hr mRNA was expressed in the epithelial cells of the tooth, consistent with its general expression in epithelial tissue and cells of epithelial origin (15).
In the mouse, the expression of both hr mRNA and protein has been examined in detail during hair follicle (HF) morphogenesis and cycling (16;17). During HF morphogenesis (see Background), hr mRNA is consistently expressed in the undifferentiated suprabasal cell layers of the interfollicular epidermis, the HF infundibulum, the hair matrix, and in the inner root sheath (IRS). The dermal papilla (DP) and outer root sheath (ORS) were negative for hr mRNA (16). During the mouse hair cycle, follicles actively growing hair in anagen do not contain detectable HR protein. HR is detected as follicles enter catagen, and is present in keratin 14 (K14)-positive progenitor cells in the ORS, which includes the bulge region. HR is also detected in K14-negative hair bulb cells. This expression is maintained through the resting telogen phase and into the early part of the next anagen. HR protein again becomes undetectable once the hair bulb has formed. Hr mRNA shows a slightly different expression pattern during the hair cycle with hr mRNA being present throughout anagen (16).
In the rat, Northern analysis of RNA isolated from embryonic and postnatal brain shows that hr is expressed at high levels shortly after birth, reaching a peak between postnatal days (P) 14 and 21. Neonatal expression of hr is abundant in brain and skin and is also detected at low levels in other tissues, including gut, lung, muscle, pituitary, testes, and thymus. The expression pattern is similar in adult tissues (2). In situ hybridization experiments show that hr is broadly expressed at low levels throughout the forebrain and midbrain at P14 and P15, with high levels in the cortex, hippocampus, thalamus, and cerebellum (2;18). In the cerebellum, this expression was restricted to the differentiated cells of the internal granule cell layer (IGL) (2). Hr is also expressed in the cochlear nucleus and inferior colliculus of the auditory system. In addition, hr is expressed in several fiber tracts including the corpus callosum, optic tract, internal capsule, and cerebral peduncle, indicating expression may also be in glial cells (18). Western blot analysis is agreement with these results, finding high levels of HR expression in the brain and skin with lower levels detected in lung and pituitary. In the CNS, HR protein is expressed in the cerebellum, somatosensory cortex, inferior colliculus, olfactory bulb, thalamus, optic tract, and spinal cord. In the cerebellum, HR protein is first detected at P10, remains high during postnatal development, and decreases in the adult (18).
Northern analysis of human Hairless mRNA was consistent with mouse and rat data, with substantial expression in the brain and skin, moderate expression in the heart and trace expression in all other tissues (3). RT-PCR analysis supported these findings with HR mRNA expressed in skin, small intestine, brain, testes, and colon with trace levels detected in liver, kidney, pancreas, spleen and thymus. Interestingly, RT-PCR analysis suggested that human skin only expressed the shorter Hairless isoform (see Protein Prediction) (4).
In the mouse, the classical hairless (hr) and rhino (hrrh) homozygous mutants with mutations in the hairless gene develop a normal first coat, but do not reinitiate subsequent hair cycles resulting in alopecia (1;15;24). Histologically, the skin of hairless and rhino mice are normal until the first hair cycle is nearly complete. Just before the normal loss of the first coat, the hair follicles of these mutants appear altered. The pilary canals widen, hair club formation is abnormal, with the IRS coalescing around the terminal part of the hair shaft so that the lower part of the ORS fails to follow the ascending hair club and becomes stranded in the dermis. As the mutant animals age there is hypertrophy of the sebaceous glands, loss of adipose tissue, and the development of various types of cysts from the hyperkeratotic upper part of the hair canals, and the sheaths of the abnormal follicles stranded in the dermis (24-26). Some dermal cysts may arise from sebaceous glands as they express stearoyl-coenzyme A desaturase 1 mRNA (Scd1; mutated in flake), and most cysts contain lipids. Cells in the cysts remain undifferentiated (26). Toward the end of HF morphogenesis, the proximal hair bulb undergoes premature and massive apoptosis associated with a lack of coordination of cell proliferation in defined HF compartments (25). Although the hair follicle defects in both hairless and rhino mutants are similar, animals homozygous for rhino alleles also develop thickened and severely wrinkled skin (15). The hr allele is caused by an integration of the murine leukemia virus pmv43 in intron 6 of the hr gene (1), and the presence of some correctly spliced mRNA is observed in hr/hr animals. In contrast, most rhino mutations cause protein truncation and likely lead to non-functional HR proteins (15;26). The generation of hr knockout mice resulted in animals with a phenotype similar to the most severe rhino mutants (24;26).
Along with alopecia, mice with mutations in the hr gene exhibit various other defects including abnormalities found in the colon, retina, inner ear and thymus. The thickness of the inner plexiform and ganglion cell layers in the retina was reduced in hrrh relative to wild type controls, while the number of neurons in the cochlea was also reduced and animals had a severe loss of both inner and outer hair cells with most of the remaining hair cells lacking stereocilia. In addition, hr homozygous mice were found to have defects in gravity receptor neural function of the inner ear (27). In the colon, mutant animals had an increased number of villi, while villi in the ileum area were shorter and extremely fragile (15). The thymus of hairless mouse mutants show significant atrophy that increases with age (15;28). Accordingly, various immunological defects have been reported for hr mutant mice including increased incidences of leukemia due to higher viral titers (29) and a lower cellular immune response to tumor viruses (30). Hr animals display a relative deficiency in spleen T helper CD5+ cells at 3 months of age, and decreased cell proliferation in response to alloantigens and mitogen stimulation (31-33). Although one report suggests hr animals have a defect in natural killer (NK) cell function (34), other data suggests cytotoxic NK and T cell responses are normal (33). Mice homozygous for the hr mutation are much more sensitive to UV and chemically induced skin tumors than shaved controls (35;36).
Multiple studies have established that HR is a nuclear receptor corepressor. Nuclear receptors are transcription factors whose function is regulated by the binding of lipophilic ligands. Upon binding of ligands, nuclear receptors are transported into the nucleus where they most often activate target gene transcription. A subset of nuclear receptors, including the thyroid hormone receptors (TRs), vitamin D receptor (VDR), and retinoic acid receptors (RARs/RXRs) also repress transcription in the absence of their ligand. The transcriptional activity of nuclear receptors depends on the association of coactivators and corepressors, many of which function in chromatin remodeling. Most nuclear receptor corepressors facilitate repression via their association with histone deacetylases (HDACs) (37;38). HR interacts with and mediates the repressive activity of multiple nuclear receptors including TRs, retinoic acid receptor-related orphan receptor α (RORα), and VDR (8-10;19). Although HR does not directly interact with HDACs, it is a component of HDAC protein complexes and colocalizes with HDAC proteins in the nuclear matrix (7;8;18).
In humans, at least 28 different mutations in the Hairless gene cause Alopecia Universalis Congenita or congenital atrichia (AUC; OMIM #203655) and Atrichia with Papular Lesions (APL; OMIM #209500), including missense, nonsense, splice-site and deletion/insertion mutations (3;39). Patients with these conditions are normally born with hair that subsequently falls out resulting in a complete or nearly complete absence of all hair. Histological studies show malformation of the hair follicles, similar to mice carrying pathogenic alleles of the hr gene (24;40). Patients with APL also exhibit papular lesions, analogous to the cysts found in hairless mutant mice. Despite the presence of immunological defects and other abnormalities present in hr mutant mice, humans with mutations in the HR gene do not have any evidence of immune dysfunction, susceptibility to skin tumors, or deafness (3). HR does not appear to be involved in the development of androgenetic alopecia (AGA; OMIM %109200), as no polymorphic differences were found in the HR gene in patients with AGA (41).
Increasing evidence supports the model that HR acts as a repressor in vivo to regulate hair and skin morphogenesis. Detailed examination of skin and hair follicles in hr-/- mice suggests that the skin wrinkling observed in certain hairless mutants is due to increased cell proliferation in the epidermis, and analysis of gene expression in hr-/- skin revealed upregulation of keratinocyte terminal differentiation markers including caspase 14 and Keratin 10 (mutated in Rough-fur) (26). Additionally, expression of early markers of hair differentiation including sonic hedgehog (Shh) and components of the Wnt signaling pathway are not detected in hr-/- skin as the hair cycle fails in these animals. It is likely that HR acts through the Wnt signaling pathway to regulate hair cycling as HR inhibits the expression of Wise (Wnt modulator in surface ectoderm) during follicle regeneration (17;23). Importantly, Wise can inhibit signaling by Wnt10b (17), one of two Wnts expressed in hair follicles (49). Through Wise, HR may also regulate BMP (bone morphogenetic protein) signaling in the hair follicle as Wise is a potential inhibitor of BMP signaling (50). Finally, it is likely that HR negatively regulates the expression of ornithine decarboxylase (ODC) in the skin. Transgenic mice overexpressing ornithine decarboxylase (ODC) in the outer root sheath of the hair follicle develop a skin phenotype that is similar to homozygous hr and rhino mice (51;52). Chemical or UV stimulation of hr/hr skin produces a significant increase in ODC activity in the epidermis suggesting that overexpression of ODC may cause the susceptibility to skin tumors seen in mice carrying different mutations at hairless (35;36).
HR is likely to regulate hair cell cycling by modulating gene expression through its interaction with various nuclear receptors. In vitro testing of HR proteins generated with point mutations found in pathogenic human alleles of HR discovered that these HR proteins were capable of interacting with nuclear receptors, but were not capable of repressive activity and were defective in HDAC interaction in vitro (42). The alopecia and papular lesions induced by VDR mutations in humans are very similar to those seen in patients with Hr mutations (40;43). VDR null mice also have initial hair growth that subsequently fails (44), and hr and VDR mRNAs are coexpressed in the hair follicle (10). An activation defective VDR can rescue hair loss in VDR null mice, suggesting that the activation function of VDR is not required for hair growth. This mutant is able to interact with HR and repress basal transcription, providing evidence that the repressive role of VDR through HR is important for regulating hair cycling (29). Although HR does not interact directly with retinoid X receptors (RXRs), RXR receptors are known to form heterodimers with other nuclear receptors including VDR. A skin-specific RXRα knockout, as well as an ENU-generated missense mutation in RXRα, result in animals exhibiting progressive alopecia and cyst formation (please see the record for pinkie) (45-47). Interestingly, it appears that hr is itself repressed by VDR as hr mRNA is upregulated in VDR-deficient animals (44). These results suggest that HR and the VDR/RXRα heterodimer may be involved in the same pathway during regulation of the hair follicle. However, VDR-null mice do not exhibit the severe wrinkling found in many hr mutant animals, suggesting that HR also acts through other pathways in the skin. Since thyroid hormone deficient humans and mice exhibit hair loss and skin defects, and TRs are expressed in most cells of the hair follicle, it is possible HR also interacts with TR in the skin and hair follicle to regulate skin and hair cycling (48).
Hr was found to be a thyroid hormone (TH) responsive gene in the developing rat brain (2), and is expressed at high levels in the brains of rats, mice and humans (1-3;15;18), suggesting it may have a role in brain development or maintenance. Hr expression is significantly lower in the brains of TRα- and TRα1-deficient animals and hypothyroid rats (2;18), and alterations in the size of cerebellar Purkinje cells have been reported for hr mutant mice and TH-deficient animals (54;55). In humans, the lack of thyroid hormone during a critical perinatal period leads to mental retardation and cerebellar ataxia (55), although no neurological defects have been noted for either mice or humans with mutations in the HR gene (3;15). However, the cochlear defects seen in hr mutant mice are similar to those found in congenital hypothyroid mutant mice and human TH deficiency disorders (15;55;56).
The immunological defects found in some alleles of hairless are likely due to thymic abnormalities caused by defects in thymic epithelial cells as hr is expressed in and may have function in many epithelial cell types (15;28). Hr is not expressed in mouse thymus, although low levels of thymic expression have been reported in rats and humans (2;4). It is possible that hairless is expressed at low levels in the mouse or transiently during development, causing later thymic atrophy. Mice with mutations in RXRα, which may interact with VDR and HR to regulate hair cycling, also exhibit alterations in T cell differentiation displaying a progressive impairment in T helper type 2 (Th2) antigen-specific IgG1 production following immunization with ovalbumin and alum (45). This suggests that RXRα may also interact with HR to regulate T cell differentiation. However, not all alleles of hr have immunological defects (53), and some reports are inconsistent (33;34), making it unclear if the immunological deficiencies observed in hairless mutant mice may be due to genetic background or modifiers.
Prune, with its extremely wrinkled skin, closely resembles the rhino and knockout alleles of hr, suggesting that tyrosine 1082 is critical for HR repressive activity. Tyrosine 1082 is highly conserved across species (1-3) and is located in the JmjC domain, which may mediate histone demethylase activity (14). In humans, the region of the JmjC domain containing this tyrosine does not appear to be present in the skin-specific isoform of HR (4). Moreover, none of the pathogenic human mutations causing APL/AUC are located in this region, although several are found in other parts of the JmjC domain (39). Our results suggest a possible difference between the mouse and human HR proteins despite the high conservation found in this region. Unlike mice, which exhibit phenotypic differences depending on the severity of the mutation, the phenotypic severity in humans has not been correlated with genotype, although several of the human alleles do cause protein truncations (39). Immunological phenotypes of prune are currently being investigated.
|Primers||Primers cannot be located by automatic search.|
Prune genotyping is performed by amplifying the region containing the mutation using PCR, followed by sequencing of the amplified region to detect the single nucleotide change.
Primers for PCR amplification
Prune(F): 5’- TCCTGGGTTTTGGAGAAAGGGACAC -3’
Prune(R): 5’- AGCCGCCTTTACTGCTTGGAACAC -3’
1) 94°C 2:00
2) 94°C 0:30
3) 56°C 0:30
4) 72°C 1:00
5) repeat steps (2-4) 29X
6) 72°C 7:00
7) 4°C ∞
Primers for sequencing
Prune_seq(F): 5’- CCAGGGTCACAGAAGCTATG -3’
Prune_seq(R): 5’- GAATGCTGTATGATCAGGACTCC -3’
The following sequence of 1248 nucleotides (from Genbank genomic region NC_000080 for linear DNA sequence of hr) is amplified:
16981 gttttggaga aagggacacg gagagaacaa ggggtcaggc cagggtcaca gaagctatga
17041 aaagcacatc ccagggaagg cagggattta gatccctcct cccaccccca gcttgagtgt
17101 cccttactct aagctccttc caatccaacc tggacctacc cccatcctgt cctatccctt
17161 accaccaacc ctcctctctc ctacctcttc cttcttttgc ctgcccttca agacagcttc
17221 agcaccctat tgaacctgat cttccaaaga gtccactccc cttcctctct gaatgcttgc
17281 cttcatcccc actgacattc atcttccttt ctcttcttga aggtgtgccc agctggagca
17341 ggaaccttgg agcctggtgc cccaggcagc tgctacttgg atgcagggtt gcgccgacgg
17401 ctaagagaag agtggggtgt gagctgctgg accctgctgc aggctcctgg ggaagcggtg
17461 ctggtcccgg ctggggcgcc ccatcaggtg cttacctggt gggtgggggt taacaaaaga
17521 tcagagtatc agaagtagca aggagtcctg atcatacagc attctctacc tgatagaaag
17581 ctaggcaggg caggaagcca tggagataga aagccaaggg tcttgaagtc ttcaaagcta
17641 tgtgggactc tctccagcat ccctcaggtc ttgttctggc catggccttt tgaatgtctg
17701 gttctgtaac tagggttggt tactgttttc tgaaagttgg ataaggaagt agacttagtg
17761 atcagaggca tggaggggga atgtggtttg agcctcaact caccctctct tgcccttgtt
17821 ccgcccccct ccctgcccac cccacggcac aggtgcaggg cctggtgagc acaatcagtg
17881 tcactcagca ctttctgtct cctgagacct ctgccctctc tgctcagctc taccaccagg
17941 gagccagcct accccctgac caccgtatgc tttatgccca ggtgagtgtg gtactggctt
18001 gaaggcagag tgtgctgctg ccctagtctc cttggggcac agccgcagta ggcaggacag
18061 atctgtctga gtggaatggg ctgctagcct gtcagtgcta gataaaggtg ttcttgagaa
18121 gggtagggag tgagggttgg tgctggaacg cgattgaaaa ttctgtgtca tttttctttt
18181 tcccagatgg accgggctgt gttccaagca gtaaaggcgg ct
PCR primer binding sites are underlined; sequencing primer binding sites are highlighted in gray; the mutated T is shown in red text.
1. Cachon-Gonzalez, M. B., Fenner, S., Coffin, J. M., Moran, C., Best, S., and Stoye, J. P. (1994) Structure and expression of the hairless gene of mice, Proc. Natl. Acad. Sci. U. S A 91, 7717-7721.
2. Thompson, C. C. (1996) Thyroid hormone-responsive genes in developing cerebellum include a novel synaptotagmin and a hairless homolog, J Neurosci. 16, 7832-7840.
3. Ahmad, W., Faiyaz ul, H. M., Brancolini, V., Tsou, H. C., ul, H. S., Lam, H., Aita, V. M., Owen, J., deBlaquiere, M., Frank, J., Cserhalmi-Friedman, P. B., Leask, A., McGrath, J. A., Peacocke, M., Ahmad, M., Ott, J., and Christiano, A. M. (1998) Alopecia universalis associated with a mutation in the human hairless gene, Science 279, 720-724.
4. Cichon, S., Anker, M., Vogt, I. R., Rohleder, H., Putzstuck, M., Hillmer, A., Farooq, S. A., Al-Dhafri, K. S., Ahmad, M., Haque, S., Rietschel, M., Propping, P., Kruse, R., and Nothen, M. M. (1998) Cloning, genomic organization, alternative transcripts and mutational analysis of the gene responsible for autosomal recessive universal congenital alopecia, Hum. Mol. Genet 7, 1671-1679.
5. Weiss, M. J. and Orkin, S. H. (1995) GATA transcription factors: key regulators of hematopoiesis, Exp. Hematol. 23, 99-107.
6. Djabali, K., Aita, V. M., and Christiano, A. M. (2001) Hairless is translocated to the nucleus via a novel bipartite nuclear localization signal and is associated with the nuclear matrix, J Cell Sci. 114, 367-376.
7. Djabali, K. and Christiano, A. M. (2004) Hairless contains a novel nuclear matrix targeting signal and associates with histone deacetylase 3 in nuclear speckles, Differentiation 72, 410-418.
8. Potter, G. B., Beaudoin, G. M., III, DeRenzo, C. L., Zarach, J. M., Chen, S. H., and Thompson, C. C. (2001) The hairless gene mutated in congenital hair loss disorders encodes a novel nuclear receptor corepressor, Genes Dev. 15, 2687-2701.
9. Moraitis, A. N., Giguere, V., and Thompson, C. C. (2002) Novel mechanism of nuclear receptor corepressor interaction dictated by activation function 2 helix determinants, Mol. Cell Biol. 22, 6831-6841.
10. Hsieh, J. C., Sisk, J. M., Jurutka, P. W., Haussler, C. A., Slater, S. A., Haussler, M. R., and Thompson, C. C. (2003) Physical and functional interaction between the vitamin D receptor and hairless corepressor, two proteins required for hair cycling, J Biol. Chem. 278, 38665-38674.
11. Glass, C. K., Rose, D. W., and Rosenfeld, M. G. (1997) Nuclear receptor coactivators, Curr. Opin. Cell Biol. 9, 222-232.
12. Nagy, L., Kao, H. Y., Love, J. D., Li, C., Banayo, E., Gooch, J. T., Krishna, V., Chatterjee, K., Evans, R. M., and Schwabe, J. W. (1999) Mechanism of corepressor binding and release from nuclear hormone receptors, Genes Dev. 13, 3209-3216.
13. Perissi, V., Staszewski, L. M., McInerney, E. M., Kurokawa, R., Krones, A., Rose, D. W., Lambert, M. H., Milburn, M. V., Glass, C. K., and Rosenfeld, M. G. (1999) Molecular determinants of nuclear receptor-corepressor interaction, Genes Dev. 13, 3198-3208.
14. Tsukada, Y., Fang, J., Erdjument-Bromage, H., Warren, M. E., Borchers, C. H., Tempst, P., and Zhang, Y. (2006) Histone demethylation by a family of JmjC domain-containing proteins, Nature 439, 811-816.
15. Cachon-Gonzalez, M. B., San-Jose, I., Cano, A., Vega, J. A., Garcia, N., Freeman, T., Schimmang, T., and Stoye, J. P. (1999) The hairless gene of the mouse: relationship of phenotypic effects with expression profile and genotype, Dev. Dyn. 216, 113-126.
16. Panteleyev, A. A., Paus, R., and Christiano, A. M. (2000) Patterns of hairless (hr) gene expression in mouse hair follicle morphogenesis and cycling, Am. J Pathol. 157, 1071-1079.
17. Beaudoin, G. M., III, Sisk, J. M., Coulombe, P. A., and Thompson, C. C. (2005) Hairless triggers reactivation of hair growth by promoting Wnt signaling, Proc. Natl. Acad. Sci. U. S A 102, 14653-14658.
18. Potter, G. B., Zarach, J. M., Sisk, J. M., and Thompson, C. C. (2002) The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain, Mol. Endocrinol. 16, 2547-2560.
19. Thompson, C. C. and Bottcher, M. C. (1997) The product of a thyroid hormone-responsive gene interacts with thyroid hormone receptors, Proc. Natl. Acad. Sci. U. S A 94, 8527-8532.
20. Ito, M., Tazawa, T., Shimizu, N., Ito, K., Katsuumi, K., Sato, Y., and Hashimoto, K. (1986) Cell differentiation in human anagen hair and hair follicles studied with anti-hair keratin monoclonal antibodies, J. Invest Dermatol. 86, 563-569.
21. Muller-Rover, S., Handjiski, B., van, d., V, Eichmuller, S., Foitzik, K., McKay, I. A., Stenn, K. S., and Paus, R. (2001) A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages, J. Invest Dermatol. 117, 3-15.
23. Thompson, C. C., Sisk, J. M., and Beaudoin, G. M., III (2006) Hairless and Wnt signaling: allies in epithelial stem cell differentiation, Cell Cycle 5, 1913-1917.
24. Panteleyev, A. A., Paus, R., Ahmad, W., Sundberg, J. P., and Christiano, A. M. (1998) Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans, Exp. Dermatol. 7, 249-267.
25. Panteleyev, A. A., Botchkareva, N. V., Sundberg, J. P., Christiano, A. M., and Paus, R. (1999) The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation, Am. J Pathol. 155, 159-171.
26. Zarach, J. M., Beaudoin, G. M., III, Coulombe, P. A., and Thompson, C. C. (2004) The co-repressor hairless has a role in epithelial cell differentiation in the skin, Development 131, 4189-4200.
27. Jones, S. M., Johnson, K. R., Yu, H., Erway, L. C., Alagramam, K. N., Pollak, N., and Jones, T. A. (2005) A quantitative survey of gravity receptor function in mutant mouse strains, J Assoc. Res. Otolaryngol. 6, 297-310.
28. San, J., I, Garcia-Suarez, O., Hannestad, J., Cabo, R., Gauna, L., Represa, J., and Vega, J. A. (2001) The thymus of the hairless rhino-j (hr/rh-j) mice, J Anat. 198, 399-406.
29. Heiniger, H. J., Huebner, R. J., and Meier, H. (1976) Effect of allelic substitutions at the hairless locus on endogenous ecotropic murine leukemia virus titers and leukemogenesis, J Natl. Cancer Inst. 56, 1073-1074.
30. Johnson, D. A. and Meier, H. (1981) Immune responsiveness of HRS/J mice to syngeneic lymphoma cells, J Immunol. 127, 461-464.
31. Reske-Kunz, A. B., Scheid, M. P., and Boyse, E. A. (1979) Disproportion in T-cell subpopulations in immunodeficient mutant hr/hr mice, J Exp. Med. 149, 228-233.
32. Morrissey, P. J., Parkinson, D. R., Schwartz, R. S., and Waksal, S. D. (1980) Immunologic abnormalities in HRS/J mice. I. Specific deficit in T lymphocyte helper function in a mutant mouse, J Immunol. 125, 1558-1562.
33. Harris, D. T., LoCascio, J., Acevedo, A., Olson, G. B., Bard, J., and Boyse, E. A. (1993) Analysis of the hairless mouse as a model for the effects of aging on the immune system, Immunol. Lett 36, 19-26.
34. Clark, E. A., Shultz, L. D., and Pollack, S. B. (1981) Mutations in mice that influence natural killer (NK) cell activity, Immunogenetics 12, 601-613.
35. Knutson, J. C. and Poland, A. (1982) Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: interaction of the ah and hr loci, Cell 30, 225-234.
36. Berton, T. R., Fischer, S. M., Conti, C. J., and Locniskar, M. F. (1996) Comparison of ultraviolet light-induced skin carcinogenesis and ornithine decarboxylase activity in sencar and hairless SKH-1 mice fed a constant level of dietary lipid varying in corn and coconut oil, Nutr. Cancer 26, 353-363.
37. McKenna, N. J. and O'Malley, B. W. (2002) Combinatorial control of gene expression by nuclear receptors and coregulators, Cell 108, 465-474.
38. Privalsky, M. L. (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors, Annu. Rev. Physiol 66, 315-360.
39. Paradisi, M., Masse, M., Martinez-Mir, A., Lam, H., Pedicelli, C., and Christiano, A. M. (2005) Identification of a novel splice site mutation in the human hairless gene underlying atrichia with papular lesions, Eur. J Dermatol. 15, 332-338.
40. Bergman, R., Schein-Goldshmid, R., Hochberg, Z., Ben-Izhak, O., and Sprecher, E. (2005) The alopecias associated with vitamin D-dependent rickets type IIA and with hairless gene mutations: a comparative clinical, histologic, and immunohistochemical study, Arch. Dermatol. 141, 343-351.
41. Hillmer, A. M., Kruse, R., Macciardi, F., Heyn, U., Betz, R. C., Ruzicka, T., Propping, P., Nothen, M. M., and Cichon, S. (2002) The hairless gene in androgenetic alopecia: results of a systematic mutation screening and a family-based association approach, Br. J Dermatol. 146, 601-608.
42. Wang, J., Malloy, P. J., and Feldman, D. (2007) Interactions of the vitamin D receptor with the corepressor hairless: analysis of hairless mutants in atrichia with papular lesions, J Biol. Chem. 282, 25231-25239.
43. Miller, J., Djabali, K., Chen, T., Liu, Y., Ioffreda, M., Lyle, S., Christiano, A. M., Holick, M., and Cotsarelis, G. (2001) Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene, J Invest Dermatol. 117, 612-617.
44. Bikle, D. D., Elalieh, H., Chang, S., Xie, Z., and Sundberg, J. P. (2006) Development and progression of alopecia in the vitamin D receptor null mouse, J. Cell Physiol 207, 340-353.
45. Du, X., Tabeta, K., Mann, N., Crozat, K., Mudd, S., and Beutler, B. (2005) An essential role for Rxralpha in the development of Th2 responses, Eur. J. Immunol. 35, 3414-3423.
46. Li, M., Indra, A. K., Warot, X., Brocard, J., Messaddeq, N., Kato, S., Metzger, D., and Chambon, P. (2000) Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis, Nature 407, 633-636.
47. Li, M., Chiba, H., Warot, X., Messaddeq, N., Gerard, C., Chambon, P., and Metzger, D. (2001) RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations, Development 128, 675-688.
48. Alonso, L. C. and Rosenfield, R. L. (2003) Molecular genetic and endocrine mechanisms of hair growth, Horm. Res. 60, 1-13.
49. Reddy, S., Andl, T., Bagasra, A., Lu, M. M., Epstein, D. J., Morrisey, E. E., and Millar, S. E. (2001) Characterization of Wnt gene expression in developing and postnatal hair follicles and identification of Wnt5a as a target of Sonic hedgehog in hair follicle morphogenesis, Mech. Dev. 107, 69-82.
50. Laurikkala, J., Kassai, Y., Pakkasjarvi, L., Thesleff, I., and Itoh, N. (2003) Identification of a secreted BMP antagonist, ectodin, integrating BMP, FGF, and SHH signals from the tooth enamel knot, Dev. Biol. 264, 91-105.
51. Soler, A. P., Gilliard, G., Megosh, L. C., and O'Brien, T. G. (1996) Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity, J Invest Dermatol. 106, 1108-1113.
52. Megosh, L., Gilmour, S. K., Rosson, D., Soler, A. P., Blessing, M., Sawicki, J. A., and O'Brien, T. G. (1995) Increased frequency of spontaneous skin tumors in transgenic mice which overexpress ornithine decarboxylase, Cancer Res. 55, 4205-4209.
53. Brancaz, M. V., Iratni, R., Morrison, A., Mancini, S. J., Marche, P., Sundberg, J., and Nonchev, S. (2004) A new allele of the mouse hairless gene interferes with Hox/LacZ transgene regulation in hair follicle primordia, Exp. Mol. Pathol. 76, 173-181.
54. Garcia-Atares, N., San, J., I, Cabo, R., Vega, J. A., and Represa, J. (1998) Changes in the cerebellar cortex of hairless Rhino-J mice (hr-rh-j), Neurosci. Lett 256, 13-16.
55. Thompson, C. C. and Potter, G. B. (2000) Thyroid hormone action in neural development, Cereb. Cortex 10, 939-945.
|Science Writers||Nora G. Smart|
|Illustrators||Diantha La Vine|
|Authors||Owen M. Siggs, Bruce Beutler|
|List |< first << previous [record 6 of 17] next >> last >||